Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Erb

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Geriatric Psychiatry|May 7, 2009
The effect of aging on the inhibitory function in middle-aged subjects: a functional MRI study coupled with a color-matched Stroop taskAlexandre Mathis, Thérèse Schunck, Gilles Erb, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancerMarius Ilie, Mélanie Beaulande, Marame Hamila, et al.
Journal of Psychopharmacology (Oxford, England)|May 26, 2010
One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRIThérèse Schunck, Alexandre Mathis, Gilles Erb, et al.
Dialogues in Clinical Neuroscience|October 29, 2011
fMRI in anxietyThérèse Schunck, Gilles Erb, Christian Gilles, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 1, 2008
Test-retest reliability of a functional MRI anticipatory anxiety paradigm in healthy volunteersThérèse Schunck, Gilles Erb, Alexandre Mathis, et al.
Neuroimage|April 8, 2006
Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxietyThérèse Schunck, Gilles Erb, Alexandre Mathis, et al.
Dialogues in Clinical Neuroscience|October 29, 2011
Human models as tools in the development of psychotropic drugsChristian Gilles, Thérèse Schunck, Gilles Erb, et al.
ESMO Open|September 25, 2018
ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?Florian Cabillic, Paul Hofman, Marius Ilie, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 29, 2022
Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC)Florin Dobritoiu, Adelina Baltan, Alina Chefani, et al.
Cancer Medicine|April 29, 2023
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinomaElisabeth G E de Vries, Josef Rüschoff, Martijn Lolkema, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Geriatric Psychiatry|May 7, 2009
The effect of aging on the inhibitory function in middle-aged subjects: a functional MRI study coupled with a color-matched Stroop taskAlexandre Mathis, Thérèse Schunck, Gilles Erb, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancerMarius Ilie, Mélanie Beaulande, Marame Hamila, et al.
Journal of Psychopharmacology (Oxford, England)|May 26, 2010
One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRIThérèse Schunck, Alexandre Mathis, Gilles Erb, et al.
Dialogues in Clinical Neuroscience|October 29, 2011
fMRI in anxietyThérèse Schunck, Gilles Erb, Christian Gilles, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 1, 2008
Test-retest reliability of a functional MRI anticipatory anxiety paradigm in healthy volunteersThérèse Schunck, Gilles Erb, Alexandre Mathis, et al.
Neuroimage|April 8, 2006
Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxietyThérèse Schunck, Gilles Erb, Alexandre Mathis, et al.
Dialogues in Clinical Neuroscience|October 29, 2011
Human models as tools in the development of psychotropic drugsChristian Gilles, Thérèse Schunck, Gilles Erb, et al.
ESMO Open|September 25, 2018
ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?Florian Cabillic, Paul Hofman, Marius Ilie, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 29, 2022
Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC)Florin Dobritoiu, Adelina Baltan, Alina Chefani, et al.
Cancer Medicine|April 29, 2023
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinomaElisabeth G E de Vries, Josef Rüschoff, Martijn Lolkema, et al.
Pageof 2